3/31
12:00 pm
cort
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Low
Report
Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
3/31
12:00 pm
cort
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
3/31
09:00 am
cort
CORT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Corcept Therapeutics Incorporated Securities Lawsuit -- The Gross Law Firm
Low
Report
CORT Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Corcept Therapeutics Incorporated Securities Lawsuit -- The Gross Law Firm
3/30
10:05 pm
cort
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Medium
Report
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
3/30
04:21 pm
cort
Corcept Gains FDA Approval In Ovarian Cancer (Rating Upgrade) [Seeking Alpha]
Medium
Report
Corcept Gains FDA Approval In Ovarian Cancer (Rating Upgrade) [Seeking Alpha]
3/30
04:00 pm
cort
April 21, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CORT
Medium
Report
April 21, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CORT
3/30
03:56 pm
cort
CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Low
Report
CORT INVESTOR ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
3/30
11:30 am
cort
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
3/30
09:00 am
cort
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors
Low
Report
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors
3/30
04:10 am
cort
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
Low
Report
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
3/30
04:09 am
cort
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
Low
Report
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
3/29
09:11 pm
cort
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Low
Report
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
3/28
02:55 pm
cort
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session [Yahoo! Finance]
Low
Report
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session [Yahoo! Finance]
3/28
02:45 pm
cort
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
Low
Report
Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
3/27
11:40 pm
cort
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC [TheStreet.com]
Low
Report
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC [TheStreet.com]
3/27
10:25 pm
cort
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Low
Report
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
3/27
09:03 pm
cort
Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week [Yahoo! Finance]
Low
Report
Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week [Yahoo! Finance]
3/27
06:26 pm
cort
Why Corcept Therapeutics (CORT) Is Up 8.5% After First-in-Class Lifyorli FDA Cancer Approval – And What's Next [Yahoo! Finance]
Low
Report
Why Corcept Therapeutics (CORT) Is Up 8.5% After First-in-Class Lifyorli FDA Cancer Approval – And What's Next [Yahoo! Finance]
3/27
02:26 pm
cort
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Low
Report
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
3/27
12:00 pm
cort
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
Low
Report
Bronstein, Gewirtz & Grossman LLC Urges Corcept Therapeutics Incorporated Investors to Act: Class Action Filed Alleging Investor Harm
3/27
10:59 am
cort
CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics Incorporated Securities Class Action Lawsuit — The Gross Law Firm
Low
Report
CORT Shareholder Alert: April 21, 2026 Lead Plaintiff Deadline in Corcept Therapeutics Incorporated Securities Class Action Lawsuit — The Gross Law Firm
3/26
11:04 pm
cort
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
Medium
Report
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit
3/26
06:16 pm
cort
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Low
Report
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
3/26
05:22 pm
cort
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant) [Yahoo! Finance]
Medium
Report
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant) [Yahoo! Finance]
3/26
04:42 pm
cort
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Low
Report
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss